Global Health/Biotechnology
Vanguard Health Care Fund
Last updated: 2026-09-03
The Verdict
Vanguard Health Care Fund charges an expense ratio of 0.33%. On a $100,000 portfolio, that's $330 per year in fees, and it scales with the amount invested. Supreme.PM's decoded model tracked it at 97% correlation, for a flat monthly subscription that does not change with portfolio size.
Expense Ratio
0.33%
Star Rating
3/ 5
Market Beta
0.91
Model Correlation
97%
Sharpe Ratio
0.45
Max Drawdown
23.40%
Supreme.PM Cost
Flat monthly subscription
Not a percentage of your assets
Performance
Performance comparison — 1Y: Fund 30.1% vs Model 32.1%; 3Y: Fund 28.4% vs Model 32.5%; 5Y: Fund 36.3% vs Model 38.7%.
Alpha After Fees
Supreme.PM's model achieves 97% correlation with Vanguard Health Care Fund, providing similar exposure at a flat subscription cost.
Fee Analysis
Vanguard Health Care Fund charges 0.33% of assets annually. Supreme.PM charges a flat monthly subscription instead, so its cost does not rise as a portfolio grows.
Data sources: Refinitiv Lipper, SEC EDGAR Filings, Supreme.PM Analytics
Past performance does not guarantee future results. Model returns are backtested and may not reflect actual trading conditions.
Related
Global Health/Biotechnology Category
Browse all Global Health/Biotechnology funds
Global Health/Biotechnology Rankings
Top-rated Global Health/Biotechnology funds
Our Methodology
How we decode fund strategies
Eaton Vance Worldwide Health Sciences Fund
3-star rated
Fidelity Healthy Future Fund
4-star rated
Invesco Health Care Fund
3-star rated
Janus Henderson Global Life Sciences Fund
5-star rated
Fidelity Select Pharmaceuticals Portfolio
5-star rated
Frequently Asked Questions
What is the expense ratio of Vanguard Health Care Fund?
Vanguard Health Care Fund has an expense ratio of 0.33%, charged as a percentage of the amount invested. Supreme.PM's decoded model is offered for a flat monthly subscription instead.
How does Supreme.PM replicate Vanguard Health Care Fund?
Supreme.PM builds a transparent, rules-based model of listed securities designed to track this fund's return profile. Over the measured period it tracked the fund closely, at 97% correlation. The model is published in full, so its positions are visible rather than disclosed with a delay.
What are the risks of fund replication?
While our models aim for high correlation, they may not perfectly match the fund's returns due to timing differences in rebalancing, transaction costs, and disclosure delays. Backtested results may not reflect future performance.
Get This Strategy
Start investing with Supreme.PM's decoded model and save on fees while capturing similar returns.